Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Reviews in Musculoskeletal Medicine
Published in: Current Reviews in Musculoskeletal Medicine 3/2018

01-09-2018 | Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Perioperative and Modifiable Risk Factors for Periprosthetic Joint Infections (PJI) and Recommended Guidelines

Authors: Vignesh K. Alamanda, Bryan D. Springer

Published in: Current Reviews in Musculoskeletal Medicine | Issue 3/2018

Login to get access

Abstract

Purpose of Review

Periprosthetic joint infection (PJI) remains a complication that is associated with high morbidity as well as high healthcare expenses. The purpose of this review is to examine patient and perioperative modifiable risk factors that can be altered to help improve rates of PJI.

Recent Findings

Evidence-based review of literature shows that improved control of post-operative glycemia, appropriate management of obesity, malnutrition, metabolic syndrome, preoperative anemia, and smoking cessation can help minimize risk of PJI. Additionally, use of Staphylococcus aureus screening, preoperative evaluation of vitamin D levels, screening for urinary tract infection, and examination of dental hygiene can help with improving rates of PJI; similarly, appropriate management of perioperative variables such as limiting operating room traffic, appropriate timing, and selection of prophylactic antibiotics and surgical site preparation can help to decrease rates of PJI.

Summary

In summary, PJI is a morbid complication of total joint arthroplasty. Surgeons should be vigilant of modifiable risk factors that can be improved upon to help minimize the risk of PJI.
Literature
1.
Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467(10):2606–12.CrossRefPubMedPubMedCentral
2.
Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746–51.PubMed
3.
Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplast. 2012;27(8 Suppl):61–5 e1.CrossRef
4.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.PubMed
5.
Sculco TP. The economic impact of infected total joint arthroplasty. Instr Course Lect. 1993;42:349–51.PubMed
6.
Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468(1):45–51.CrossRefPubMed
7.
Fehring TK, Odum S, Griffin WL, Mason JB, Nadaud M. Early failures in total knee arthroplasty. Clin Orthop Relat Res. 2001;392:315–8.CrossRef
8.
Vessely MB, Whaley AL, Harmsen WS, Schleck CD, Berry DJ. The Chitranjan Ranawat award: long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties. Clin Orthop Relat Res. 2006;452:28–34.CrossRefPubMed
9.
Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplast. 2008;23(7):984–91.CrossRef
10.
Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468(1):52–6.CrossRefPubMed
11.
Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408–14.CrossRefPubMed
12.
Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, et al. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clin Microbiol Infect. 2015;21(Suppl 2):S27–32.CrossRefPubMed
13.
14.
Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91(7):1621–9.CrossRefPubMed
15.
Stryker LS, Abdel MP, Morrey ME, Morrow MM, Kor DJ, Morrey BF. Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty. J Bone Joint Surg Am. 2013;95(9):808–14. S1-2 CrossRefPubMed
16.
Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141(4):375–80. discussion 80CrossRefPubMed
17.
Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplast. 2012;27(5):726–9. e1CrossRef
18.
• Chrastil J, Anderson MB, Stevens V, Anand R, Peters CL, Pelt CE. Is hemoglobin A1c or perioperative hyperglycemia predictive of Periprosthetic joint infection or death following primary Total joint arthroplasty? J Arthroplast. 2015;30(7):1197–202. New data seems to suggest that perioperative hyperglycemia may be a better target for optimization to decrease the burden of PJI. CrossRef
19.
Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS Jr. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607–12.CrossRefPubMed
20.
Richards JE, Kauffmann RM, Obremskey WT, May AK. Stress-induced hyperglycemia as a risk factor for surgical-site infection in nondiabetic orthopedic trauma patients admitted to the intensive care unit. J Orthop Trauma. 2013;27(1):16–21.CrossRefPubMedPubMedCentral
21.
Ata A, Lee J, Bestle SL, Desemone J, Stain SC. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145(9):858–64.CrossRefPubMed
22.
Workgroup of the American Association of H, Knee Surgeons Evidence Based C. Obesity and total joint arthroplasty: a literature based review. J Arthroplast. 2013;28(5):714–21.CrossRef
23.
• Mason JB, Callaghan JJ, Hozack WJ, Krebs V, Mont MA, Parvizi J. Obesity in total joint arthroplasty: an issue with gravity. J Arthroplast. 2014;29(10):1879. Commentary in the Journal of Athroplasty highlighting studies which have shown obesity to be associated with worse outcomes including infection. CrossRef
24.
Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplast. 2009;24(6 Suppl):84–8.CrossRef
25.
Winiarsky R, Barth P, Lotke P. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am. 1998;80(12):1770–4.CrossRefPubMed
26.
Gage MJ, Schwarzkopf R, Abrouk M, Slover JD. Impact of metabolic syndrome on perioperative complication rates after total joint arthroplasty surgery. J Arthroplast. 2014;29(9):1842–5.CrossRef
27.
Zmistowski B, Dizdarevic I, Jacovides CL, Radcliff KE, Mraovic B, Parvizi J. Patients with uncontrolled components of metabolic syndrome have increased risk of complications following total joint arthroplasty. J Arthroplast. 2013;28(6):904–7.CrossRef
28.
Huang R, Greenky M, Kerr GJ, Austin MS, Parvizi J. The effect of malnutrition on patients undergoing elective joint arthroplasty. J Arthroplast. 2013;28(8 Suppl):21–4.CrossRef
29.
Ellsworth B, Kamath AF. Malnutrition and total joint arthroplasty. J Nat Sci. 2016;2(3)
30.
Courtney PM, Rozell JC, Melnic CM, Sheth NP, Nelson CL. Effect of malnutrition and morbid obesity on complication rates following primary Total joint arthroplasty. J Surg Orthop Adv. 2016;25(2):99–104.CrossRefPubMed
31.
Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplast. 1991;6(4):321–5.CrossRef
32.
• Yi PH, Frank RM, Vann E, Sonn KA, Moric M, Della Valle CJ. Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty? Clin Orthop Relat Res. 2015;473(1):175–82. Study that found that patients with evidence suggestive of malnutrition to be independently associated with acute postoperative infection in the revision arthroplasty setting. CrossRefPubMed
33.
Moller AM, Pedersen T, Villebro N, Munksgaard A. Effect of smoking on early complications after elective orthopaedic surgery. J Bone Joint Surg (Br). 2003;85(2):178–81.CrossRef
34.
Sorensen LT, Jorgensen S, Petersen LJ, Hemmingsen U, Bulow J, Loft S, et al. Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis. J Surg Res. 2009;152(2):224–30.CrossRefPubMed
35.
Duchman KR, Gao Y, Pugely AJ, Martin CT, Noiseux NO, Callaghan JJ. The effect of smoking on short-term complications following Total hip and knee arthroplasty. J Bone Joint Surg Am. 2015;97(13):1049–58.CrossRefPubMed
36.
• Cherian JJ, Mont MA. Where there is smoke, there is fire! Commentary on an article by Kyle R Duchman, MD, et al: “The Effect of Smoking on Short-Term Complications Following Total Hip and Knee Arthroplasty”. J Bone Joint Surg Am. 2015;97(13):e53. Both current and former smokers are at higher risk of developing post operative wound infection. CrossRefPubMed
37.
Teng S, Yi C, Krettek C, Jagodzinski M. Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies. PLoS One. 2015;10(4):e0125294.CrossRefPubMedPubMedCentral
38.
Lindstrom D, Sadr Azodi O, Wladis A, Tonnesen H, Linder S, Nasell H, et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg. 2008;248(5):739–45.CrossRefPubMed
39.
Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke: the third National Health and nutrition examination survey, 1988 to 1991. JAMA. 1996;275(16):1233–40.CrossRefPubMed
40.
Gariti P, Alterman AI, Barber W, Bedi N, Luck G, Cnaan A. Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting. Drug Alcohol Depend. 1999;54(2):111–6.CrossRefPubMed
41.
Hurt RD, Dale LC, Offord KP, Lauger GG, Baskin LB, Lawson GM, et al. Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther. 1993;54(1):98–106.CrossRefPubMed
42.
Goyal N, Aggarwal V, Parvizi J. Methicillin-resistant Staphylococcus aureus screening in total joint arthroplasty: a worthwhile endeavor. J Knee Surg. 2012;25(1):37–43.CrossRefPubMed
43.
Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010;92(9):1820–6.CrossRefPubMed
44.
Rao N, Cannella B, Crossett LS, Yates AJ Jr, McGough R 3rd. A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res. 2008;466(6):1343–8.CrossRefPubMedPubMedCentral
45.
Peng HM, Wang LC, Zhai JL, Weng XS, Feng B, Wang W. Effectiveness of preoperative decolonization with nasal povidone iodine in Chinese patients undergoing elective orthopedic surgery: a prospective cross-sectional study. Braz J Med Biol Res. 2017;51(2):e6736.CrossRefPubMedPubMedCentral
46.
Koulouvaris P, Sculco P, Finerty E, Sculco T, Sharrock NE. Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin Orthop Relat Res. 2009;467(7):1859–67.CrossRefPubMed
47.
Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. 1991;91(3B):65S–71S.CrossRefPubMed
48.
Cruess RL, Bickel WS, vonKessler KL. Infections in total hips secondary to a primary source elsewhere. Clin Orthop Relat Res. 1975;106:99–101.CrossRef
49.
David TS, Vrahas MS. Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg. 2000;8(1):66–74.CrossRefPubMed
50.
Sousa R, Munoz-Mahamud E, Quayle J, Dias da Costa L, Casals C, Scott P, et al. Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Infect Dis. 2014;59(1):41–7.CrossRefPubMedPubMedCentral
51.
Glynn MK, Sheehan JM. The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res. 1984;185:151–4.
52.
• Wood TJ, Petruccelli D, Piccirillo L, Staibano P, Winemaker M, de Beer J. Dental hygiene in maintaining a healthy joint replacement: a survey of Canadian total joint replacement patients. COP. 2016;27(5):515–9. Most arthroplasty patients appear to have good dental hygiene in this Canadian study.
53.
Lampley A, Huang RC, Arnold WV, Parvizi J. Total joint arthroplasty: should patients have preoperative dental clearance? J Arthroplast. 2014;29(6):1087–90.CrossRef
54.
Lin CA, Takemoto S, Kandemir U, Kuo AC. Mid-term outcomes in HIV-positive patients after primary total hip or knee arthroplasty. J Arthroplast. 2014;29(2):277–82.CrossRef
55.
Parvizi J, Sullivan TA, Pagnano MW, Trousdale RT, Bolander ME. Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure. J Arthroplast. 2003;18(3):259–64.CrossRef
56.
Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheum. 2014;66(2):254–63.CrossRef
57.
Ravi B, Escott B, Shah PS, Jenkinson R, Chahal J, Bogoch E, et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 2012;64(12):3839–49.CrossRefPubMed
58.
Momohara S, Kawakami K, Iwamoto T, Yano K, Sakuma Y, Hiroshima R, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011;21(5):469–75.CrossRefPubMed
59.
• Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplast. 2017;32(9):2628–38. Important guidelines on the management of antirheumatic medications including continuing methotrexate in the perioperative period and holding biologics. CrossRef
60.
Viola J, Gomez MM, Restrepo C, Maltenfort MG, Parvizi J. Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty. J Arthroplast. 2015;30(5):846–8.CrossRef
61.
Lu M, Sing DC, Kuo AC, Hansen EN. Preoperative Anemia independently predicts 30-day complications after aseptic and septic revision Total joint arthroplasty. J Arthroplast. 2017;32(9S):S197–201.CrossRef
62.
Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012;470(10):2695–701.CrossRefPubMedPubMedCentral
63.
Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplast. 2004;19(3):281–7.CrossRef
64.
Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124–57.CrossRefPubMed
65.
Corwin HL. Blood conservation in the critically ill patient. Anesthesiol Clin North Am. 2005;23(2):363–72. viiiCrossRef
66.
St-Arnaud R. The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys. 2008;473(2):225–30.CrossRefPubMed
67.
Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48–54.CrossRefPubMed
68.
Maier GS, Horas K, Seeger JB, Roth KE, Kurth AA, Maus U. Is there an association between periprosthetic joint infection and low vitamin D levels? Int Orthop. 2014;38(7):1499–504.CrossRefPubMedPubMedCentral
69.
• Hegde V, Dworsky EM, Stavrakis AI, Loftin AH, Zoller SD, Park HY, et al. Single-dose, preoperative vitamin-D supplementation decreases infection in a mouse model of Periprosthetic joint infection. J Bone Joint Surg Am. 2017;99(20):1737–44. Early animal model studies seem to indicate that Vitamin D supplementaton decreases infection risk. CrossRefPubMed
70.
Fernandez AH, Monge V, Garcinuno MA. Surgical antibiotic prophylaxis: effect in postoperative infections. Eur J Epidemiol. 2001;17(4):369–74.CrossRefPubMed
71.
Kheir MM, Tan TL, Azboy I, Tan DD, Parvizi J. Vancomycin prophylaxis for Total joint arthroplasty: incorrectly dosed and has a higher rate of Periprosthetic infection than cefazolin. Clin Orthop Relat Res. 2017;475(7):1767–74.CrossRefPubMedPubMedCentral
72.
Fletcher N, Sofianos D, Berkes MB, Obremskey WT. Prevention of perioperative infection. J Bone Joint Surg Am. 2007;89(7):1605–18.PubMed
73.
Bosco JA 3rd, Slover JD, Haas JP. Perioperative strategies for decreasing infection: a comprehensive evidence-based approach. J Bone Joint Surg Am. 2010;92(1):232–9.PubMed
74.
Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43(3):322–30.CrossRefPubMed
75.
Allo MD, Tedesco M. Operating room management: operative suite considerations, infection control. Surg Clin North Am. 2005;85(6):1291–7. xiiCrossRefPubMed
76.
Babkin Y, Raveh D, Lifschitz M, Itzchaki M, Wiener-Well Y, Kopuit P, et al. Incidence and risk factors for surgical infection after total knee replacement. Scand J Infect Dis. 2007;39(10):890–5.CrossRefPubMed
Metadata
Title
Perioperative and Modifiable Risk Factors for Periprosthetic Joint Infections (PJI) and Recommended Guidelines
Authors
Vignesh K. Alamanda
Bryan D. Springer
Publication date
01-09-2018
Publisher
Springer US
Published in
Current Reviews in Musculoskeletal Medicine / Issue 3/2018
Electronic ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-018-9494-z

Other articles of this Issue 3/2018

Current Reviews in Musculoskeletal Medicine 3/2018 Go to the issue

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

New Innovations in the Treatment of PJI and Biofilms—Clinical and Preclinical Topics

Foot and Ankle Trauma (G Moloney, section editor)

Limited Approaches to Calcaneal Fractures

Foot and Ankle Trauma (G Moloney, section editor)

Current Concepts in Talar Neck Fracture Management

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Current Recommendations for the Diagnosis of Acute and Chronic PJI for Hip and Knee—Cell Counts, Alpha-Defensin, Leukocyte Esterase, Next-generation Sequencing

PCL Update (K Jones and M Alaia, section editors)

Posterior Cruciate Ligament: Anatomy and Biomechanics

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Staphylococcus aureus Evasion of Host Immunity in the Setting of Prosthetic Joint Infection: Biofilm and Beyond